Clinical Trial Detail

NCT ID NCT02507570
Title Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Carolina Research Professionals, LLC

prostate cancer



Radium Ra 223 dichloride

Age Groups: adult

No variant requirements are available.